弥漫性大B细胞淋巴瘤
突变
突变频率
淋巴瘤
生物
血液学
内科学
基因
肿瘤科
癌症研究
医学
遗传学
作者
Li-Yang Lyu,Yuling Nie,Abulaiti Renaguli,Xiaolong Qi,Abuduer Muhebaier,Shunsheng Zhai,An Li,Min Mao,Yan Li
出处
期刊:PubMed
[National Institutes of Health]
日期:2023-04-01
卷期号:31 (2): 403-410
标识
DOI:10.19746/j.cnki.issn.1009-2137.2023.02.014
摘要
OBJECTIVE: To investigate the mutational spectrum in young patients with diffuse large B-cell lymphoma (DLBCL) based on next generation sequencing (NGS), and to provide a basis for in-depth understanding of the molecular biological characteristics and accurate prognosis of young DLBCL. METHODS: From March 2009 to March 2021, 68 young DLBCL patients with complete initial diagnosis data from the Department of Hematology, The People's Hospital Xinjiang Uygur Autonomous Region were retrospectively analyzed, and their paraffin-embedded tissues were subjected to targeted sequencing analysis by NGS technology (including 475 Target genes), and the differences in gene mutation profiles and signaling pathways between high-risk patients with aaIPI ≥2 and low-intermediate risk patients with aaIPI <2 were compared. RESULTS: =0.013). CONCLUSION: mutations predict worse survival in the patients with the aaIPI high-risk group.
科研通智能强力驱动
Strongly Powered by AbleSci AI